SymPhysis Medical, the Galway MedTech company seeking to address the distressing condition of fluid in the chest in cancer patients, today announces a significantly strengthened senior team and plans for rapid growth as it prepares for its device’s US launch. With clearance from the US Food and Drug Administration (FDA) targeted by 2026, SymPhysis Medical […]


